Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Downgrades Albireo Pharma to Neutral

Guggenheim Downgrades Albireo Pharma to Neutral

Guggenheim analyst Seamus Fernandez downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Neutral.

byBenzinga Newsdesk

January 11, 2023

1 minute read

Guggenheim analyst Seamus Fernandez downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Neutral.

Is Your iPhone 12 Or M2 MacBook Air Safe? Apple Confirms Critical Security Flaw: Report

By Benzinga Neuro

January 19, 7:27 AM

This flaw, named 'LeftoverLocals', allows hackers to access data previously processed by the device's GPU.

AAPL

Will Apple Follow Tech Peers In Announcing A Mass Layoff This Week? Analyst Says iPhone Maker In A ‘Unique’ Position

By Shanthi Rexaline

January 30, 7:05 AM

Apple Inc.

AAPL

Analyst Ratings

Where Unum Gr Stands With Analysts

By Benzinga Insights

April 25, 4:00 PM

Unum Gr (NYSE:UNM) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

UNM

‘DeSantis Doesn’t Get It:’ Rival GOP Candidate Takes Jab At Florida Governor’s Bitcoin Know-How

By Mehab Qureshi

May 26, 8:32 AM

Republican presidential candidate Vivek Ramaswamy has accused Florida Governor Ron DeSantis of having a shallow understanding of Bitcoin (CRYPTO: BTC).

BTC

Guggenheim Downgrades Albireo Pharma to Neutral

Related Posts

Is Your iPhone 12 Or M2 MacBook Air Safe? Apple Confirms Critical Security Flaw: Report

Will Apple Follow Tech Peers In Announcing A Mass Layoff This Week? Analyst Says iPhone Maker In A ‘Unique’ Position

Where Unum Gr Stands With Analysts

‘DeSantis Doesn’t Get It:’ Rival GOP Candidate Takes Jab At Florida Governor’s Bitcoin Know-How